| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cachexia | D002100 | 21 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Diabetic Angiopathies | D003925 | 20 associated lipids |
| HIV Infections | D015658 | 20 associated lipids |
| Wounds and Injuries | D014947 | 20 associated lipids |
| Carcinoma, Ductal, Breast | D018270 | 19 associated lipids |
| Carcinoma | D002277 | 18 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Brain Infarction | D020520 | 17 associated lipids |
| Scleroderma, Systemic | D012595 | 16 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jurado S et al. | Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. | 2010 | Osteoporos Int | pmid:19436932 |
| Moran CS et al. | Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. | 2010 | Clin. Endocrinol. (Oxf) | pmid:19438902 |
| Yilmaz Y et al. | Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20942739 |
| Kobayashi-Sakamoto M et al. | Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. | 2010 | Eur. J. Haematol. | pmid:20331738 |
| Vik A et al. | Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study. | 2010 | J. Thromb. Haemost. | pmid:20738762 |
| Vanella L et al. | HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. | 2010 | Bone | pmid:19853072 |
| Ochi H et al. | The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. | 2010 | J. Orthop. Res. | pmid:19890995 |
| Walker CG et al. | Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption. | 2010 | Bone | pmid:20828639 |
| Rianthavorn P et al. | Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. | 2010 | Pediatr. Nephrol. | pmid:20676692 |
| Jules J et al. | Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. | 2010 | Expert Opin. Ther. Targets | pmid:20678025 |
| Wu XY et al. | The relationship between the levels of gonadotropic hormones and OPG, leptin, TGF-beta1 and TGF-beta2 in Chinese adult women. | 2010 | Clin. Chim. Acta | pmid:20478283 |
| Cawley NX et al. | Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. | 2010 | Am. J. Physiol. Endocrinol. Metab. | pmid:20460579 |
| Jiang R et al. | High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. | 2010 | Int. J. Cancer | pmid:19728335 |
| McAllister SS and Weinberg RA | Tumor-host interactions: a far-reaching relationship. | 2010 | J. Clin. Oncol. | pmid:20644094 |
| Gupta N et al. | IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. | 2010 | J. Immunol. | pmid:20644169 |
| Paternoster L et al. | OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. | 2010 | J. Clin. Endocrinol. Metab. | pmid:20534768 |
| van Tuyl LH et al. | Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. | 2010 | Ann. Rheum. Dis. | pmid:20525836 |
| Zhang L et al. | Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. | 2010 | Gene Ther. | pmid:20428210 |
| Pal SN et al. | Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. | 2010 | Atherosclerosis | pmid:20004897 |
| Lee JE et al. | Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. | 2010 | Diabetes Res. Clin. Pract. | pmid:20092902 |
| Flyvbjerg A | Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. | 2010 | Nat Rev Endocrinol | pmid:20098449 |
| Kochetkova EA et al. | [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease]. | 2010 | Ter. Arkh. | pmid:20873238 |
| Elias LS et al. | Markers of bone remodeling in neoplastic and bone-related lesions. | 2010 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:20955951 |
| O'Sullivan EP et al. | Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. | 2010 | Thromb. Res. | pmid:20932553 |
| Lee YH et al. | Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. | 2010 | Mol. Biol. Rep. | pmid:19642016 |
| Eagan TM et al. | Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. | 2010 | Eur. Respir. J. | pmid:19643942 |
| Nabipour I et al. | Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. | 2009 Sep-Oct | Menopause | pmid:19387415 |
| Matsubara K et al. | Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. | 2009 Nov-Dec | J. Nephrol. | pmid:19967657 |
| Tuchendler D and Bolanowski M | [The role of osteoprotegerin and vitamin D in thyroid pathology]. | 2009 Nov-Dec | Endokrynol Pol | pmid:20041365 |
| GÅ‚uszko P | [Effects of biologic antirheumatic treatments on bone metabolism in rheumatoid arthritis and ankylosing spondylitis]. | 2009 Mar-Apr | Endokrynol Pol | pmid:19396755 |
| Doschak MR et al. | Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. | 2009 Mar-Apr | Mol. Pharm. | pmid:19718808 |
| Corallini F et al. | Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin. | 2009 Jan-Mar | Eur J Histochem | pmid:19351609 |
| Kolar P et al. | Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells. | 2009 Jan-Feb | Clin. Exp. Rheumatol. | pmid:19327236 |
| Nihrane A et al. | Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. | 2009 Jan-Feb | Blood Cells Mol. Dis. | pmid:19014892 |
| Koshikawa M et al. | Elevated osteopontin levels in patients with peripheral arterial disease. | 2009 Feb-Mar | Angiology | pmid:18388057 |
| Le XK et al. | Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways. | 2009 Apr-Jun | Indian J Dent Res | pmid:19553712 |
| Shea MK et al. | Vitamin K supplementation and progression of coronary artery calcium in older men and women. | 2009 | Am. J. Clin. Nutr. | pmid:19386744 |
| Xiang GD et al. | Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes. | 2009 | Diabet. Med. | pmid:19388970 |
| Ohishi M et al. | Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. | 2009 | Am. J. Pathol. | pmid:19389927 |
| Guañabens N et al. | High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. | 2009 | J. Bone Miner. Metab. | pmid:19229472 |
| Mogi M and Kondo A | Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19393224 |
| Sun J et al. | Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating. | 2009 | Biomed. Pharmacother. | pmid:19231130 |
| Schwartz Z et al. | Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces. | 2009 | Biomaterials | pmid:19395022 |
| Miheller P et al. | Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. | 2009 | Inflamm. Bowel Dis. | pmid:19408329 |
| Kook SH et al. | Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling. | 2009 | J. Cell. Biochem. | pmid:19206164 |
| Chen BL et al. | [Effect of total flavone of Epimedium on expression of bone OPG, OPGL mRNA in ovariectomized rats]. | 2009 | Zhongguo Gu Shang | pmid:19408755 |
| Wu XT et al. | Coumestrol promotes proliferation and osteoblastic differentiation in rat bone marrow stromal cells. | 2009 | J. Biomed. Mater. Res. Part B Appl. Biomater. | pmid:19165772 |
| O'Connor RD et al. | Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. | 2009 | Bone | pmid:19414073 |
| Li Q et al. | 17beta-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro. | 2009 | Leuk. Res. | pmid:19167063 |
| Corallini F et al. | The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. | 2009 | Rheumatology (Oxford) | pmid:19168833 |
| Sato MM et al. | Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. | 2009 | Genes Cells | pmid:19170762 |
| Fili S et al. | Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors. | 2009 | Cancer Lett. | pmid:19201081 |
| Bylski D et al. | Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line. | 2009 | J Biomed Mater Res A | pmid:18449944 |
| Flint J et al. | Relationships between osteoprotegerin (OPG), receptor activator of nuclear factor kappaB ligand (RANKL), and growth hormone (GH) secretory status in short children. | 2009 | J. Pediatr. Endocrinol. Metab. | pmid:20333869 |
| Kim YD et al. | Expression of receptor activator of nuclear factor -kappaB ligand, receptor activator of nuclear factor -kappaB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats. | 2009 | Lasers Med Sci | pmid:18825474 |
| Kook SH et al. | Mechanical force augments the anti-osteoclastogenic potential of human gingival fibroblasts in vitro. | 2009 | J. Periodont. Res. | pmid:18842115 |
| Secchiero P et al. | Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye. | 2009 | J. Cell. Physiol. | pmid:18780288 |
| Kaunitz AM et al. | Postmenopausal osteoporosis: fracture risk and prevention. | 2009 | J Fam Pract | pmid:19891943 |
| Panizo S et al. | RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. | 2009 | Circ. Res. | pmid:19325147 |
| González-Calvin JL et al. | Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis. | 2009 | J. Clin. Endocrinol. Metab. | pmid:19897681 |
| Tortelli F et al. | Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. | 2009 | Tissue Eng Part A | pmid:19292676 |
| Zhu H et al. | Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function. | 2009 | Stem Cells Dev. | pmid:19374589 |
| Zhang N et al. | Relationship between age-related serum concentrations of TGF-beta1 and TGF-beta2 and those of osteoprotegerin and leptin in native Chinese women. | 2009 | Clin. Chim. Acta | pmid:19361465 |
| Huang HH et al. | Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. | 2009 | J. Cell. Physiol. | pmid:19334040 |
| Klejna K et al. | OPG/RANK/RANKL signaling system and its significance in nephrology. | 2009 | Folia Histochem. Cytobiol. | pmid:19995704 |
| Crespi R et al. | Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo. | 2009 | J. Periodontol. | pmid:19335078 |
| Suh KS et al. | Kaempferol attenuates 2-deoxy-d-ribose-induced oxidative cell damage in MC3T3-E1 osteoblastic cells. | 2009 | Biol. Pharm. Bull. | pmid:19336918 |
| McCarthy HS et al. | Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. | 2009 | J. Cell. Physiol. | pmid:18814141 |
| Stolina M et al. | The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis. | 2009 | J. Clin. Immunol. | pmid:18726678 |
| Cozzolino M | Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kappaB in the vascular system. | 2009 | Blood Purif. | pmid:19729903 |
| Anandarajah AP and Schwarz EM | Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731622 |
| Leibbrandt A and Penninger JM | RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731623 |
| D'Amelio P et al. | The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. | 2009 | J. Endocrinol. Invest. | pmid:19724159 |
| Blackwell KA et al. | Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. | 2009 | Prostaglandins Other Lipid Mediat. | pmid:19744575 |
| Kostenuik PJ et al. | Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. | 2009 | J. Bone Miner. Res. | pmid:19016581 |
| Van Campenhout A and Golledge J | Osteoprotegerin, vascular calcification and atherosclerosis. | 2009 | Atherosclerosis | pmid:19007931 |
| Yun HJ et al. | Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-alpha. | 2009 | Rheumatol. Int. | pmid:19116717 |
| Agarwal S et al. | Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. | 2009 | Rheumatol. Int. | pmid:19052752 |
| Terekeci HM et al. | Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy. | 2009 | Exp. Clin. Endocrinol. Diabetes | pmid:19053023 |
| Philippou A et al. | Systemic cytokine response following exercise-induced muscle damage in humans. | 2009 | Clin. Chem. Lab. Med. | pmid:19445648 |
| Kusumi A et al. | Passage-affected competitive regulation of osteoprotegerin synthesis and the receptor activator of nuclear factor-kappaB ligand mRNA expression in normal human osteoblasts stimulated by the application of cyclic tensile strain. | 2009 | J. Bone Miner. Metab. | pmid:19449178 |
| Tang X and Meng H | Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells. | 2009 | Arch. Oral Biol. | pmid:19464673 |
| Luckhaus C et al. | Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. | 2009 | J Neural Transm | pmid:19468818 |
| Yongchaitrakul T et al. | Osteoprotegerin induces osteopontin via syndecan-1 and phosphoinositol 3-kinase/Akt in human periodontal ligament cells. | 2009 | J. Periodont. Res. | pmid:19602124 |
| Reid PE et al. | Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. | 2009 | Mol. Cancer | pmid:19604388 |
| Xu R | Effect of whey protein on the proliferation and differentiation of osteoblasts. | 2009 | J. Dairy Sci. | pmid:19528578 |
| Pedrosa WF et al. | Immunohistochemical, tomographic and histological study on onlay bone graft remodeling. Part II: calvarial bone. | 2009 | Clin Oral Implants Res | pmid:19531103 |
| Xu Y et al. | Regulation of the response of the adult rat condyle to intermaxillary asymmetric force by the RANKL-OPG system. | 2009 | Angle Orthod | pmid:19537860 |
| Brennan TC et al. | Osteoblasts play key roles in the mechanisms of action of strontium ranelate. | 2009 | Br. J. Pharmacol. | pmid:19563530 |
| Lu TY et al. | DNA methylation and histone modification regulate silencing of OPG during tumor progression. | 2009 | J. Cell. Biochem. | pmid:19565568 |
| Chuang FH et al. | Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma. | 2009 | J. Oral Pathol. Med. | pmid:19566744 |
| Lappin DF et al. | Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. | 2009 | J. Clin. Periodontol. | pmid:19624408 |
| Yokoyama M et al. | Dynamic changes in bone metabolism in the rat temporomandibular joint after molar extraction using bone scintigraphy. | 2009 | Eur. J. Oral Sci. | pmid:19627347 |
| George A and Evans CA | Detection of root resorption using dentin and bone markers. | 2009 | Orthod Craniofac Res | pmid:19627525 |
| Hartsfield JK | Pathways in external apical root resorption associated with orthodontia. | 2009 | Orthod Craniofac Res | pmid:19627526 |
| Hagedorn C et al. | Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter. | 2009 | Arterioscler. Thromb. Vasc. Biol. | pmid:19661483 |
| Robinson H et al. | Basic synovial biology and immunopathology in psoriatic arthritis. | 2009 | J Rheumatol Suppl | pmid:19661529 |
| Wang J et al. | [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients]. | 2009 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:19662974 |
| Zhang T et al. | The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. | 2009 | Biomaterials | pmid:19665222 |
| Polyzos SA et al. | The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone. | 2009 | Horm. Metab. Res. | pmid:19670154 |